Benchmarks

Headlines

This note is just a high-level overview of market movements over the past month.

More detail is left to our other notes written during the month upon key releases/events.

Multi-assets

A stunning month for nearly everything; the Waller comments that rate cuts (as per a Taylor rule type function when inflation is almost at target) could be just 4-5 months away supported an already-ignited rally in stocks and bonds (yields lower) that lifted almost all segments of the market.

Long-duration property (NAREIT index), long-duration bonds (20+yr treasury bonds) and shares of all stripes (quality, value, growth) performed well. The only real benchmark in the red was the commodity index.

Waller’s interview, Powell’s lack of pushback, and the PCE print (essentially a hair over 2%) mean that the Fed is now cautiously confirming victory, that inflation has been defeated, and the soft landing is at the point of plane wheels touching tarmac.

Brazil was one of the best performing indices. Note, we are running this a day after month end, and so it isn’t a perfect calendar match (which is fine, the point is “how have things gone over the past month”). Brazil is keen to join OPEC, which is one of the more baffling decisions we can think of. China, the EM, and Australia towards the lower end, although still positive on average.

The S&P500 has strongly recovered the past quarter’s sell-off.

More locally, Healthcare (as CSL, COH, RMD, and FPH either recovered or rallied) performed well, and both Health and REITs are generally viewed as duration sensitive. Energy struggled with weaker oil and gas prices (a seemingly well-supplied market, to the point where OPEC is cutting, however the market continues to look less at the cuts and more at the spare capacity, which is enormous, and to look at OPEC member disharmony/disgruntlement). Plus, the US keeps ratcheting up production each time the cartel cuts, so supply deficits do not look likely anytime soon.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.